| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Matinas BioPharma Holdings, Inc. | 10%+ Owner | Warrants | 3.36M | 08 Apr 2025 | R. Eide as managing partner for Pembroke | ||
| NATHANS FAMOUS, INC. | Director | Stock Options (right to buy) | 15K | 19 Aug 2024 | Direct | ||
| Matinas BioPharma Holdings, Inc. | 10%+ Owner | Common Stock | 1.5K | 08 Apr 2025 | Direct | ||
| Matinas BioPharma Holdings, Inc. | 10%+ Owner | Series C Convertible Preferred Stock | 984 | 08 Apr 2025 | R. Eide as managing partner for Pembroke |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MTNB | Matinas BioPharma Holdings, Inc. | 08 Apr 2025 | 2 | $492K | 4/A | 10%+ Owner | 10 Apr 2025, 13:59 |
| MTNB | Matinas BioPharma Holdings, Inc. | 13 Feb 2025 | 0 | $0 | 3 | 10%+ Owner | 07 Mar 2025, 18:35 |
| NATH | NATHANS FAMOUS, INC. | 19 Aug 2024 | 1 | $0 | 4 | Director | 20 Aug 2024, 16:37 |